A Simple Daily Routine for a Sharper Memory
Misplacing keys, blanking on a name mid-conversation, walking into a room and forgetting why — these get more common with age and, on their own, aren't a sign of disease. A separate question sits underneath the everyday lapses: which daily habits actually have trial evidence behind lowering long-term memory risk, and which popular fixes are mostly marketing? We checked the research on cardiovascular health, hearing, sleep, movement, social connection, brain training, and supplements.
For most people, forgetting where you put your glasses or losing your train of thought mid-sentence is ordinary cognitive friction, not a medical event. But a real and separate body of research looks at which habits are actually linked, in controlled studies, to a lower long-term risk of serious, disease-driven memory decline — and which widely marketed fixes haven't held up when tested rigorously. We pulled together what the current peer-reviewed evidence supports across five habit areas that show up repeatedly in the research, plus what's known about training the brain directly and which supplements have real evidence behind them.
The evidence-based risk factors: what the Lancet Commission actually found
In 2024, the Lancet Commission on dementia prevention, intervention, and care — a standing panel of international dementia researchers — published an update to its widely cited risk-factor review, identifying 14 modifiable factors across the life course linked to dementia risk: low education, hearing loss, hypertension, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol consumption, traumatic brain injury, air pollution, social isolation, high LDL cholesterol, and untreated vision loss. The Commission estimated that addressing all 14 factors across a population could theoretically prevent or delay as much as 45% of dementia cases. That's a population-level statistic, not a personal guarantee — it doesn't mean any one individual who addresses these factors cuts their own risk by 45%. Several of the factors have also been tested directly in randomized trials, which is a higher evidence bar than an association alone.
Blood pressure is one of the better-tested examples. The SPRINT MIND trial randomized more than 9,300 adults age 50 and older to intensive versus standard blood pressure control and found the intensive-control group had a 19% lower rate of developing mild cognitive impairment (MCI) — a recognized precursor some people go on to develop into dementia — over a few years of follow-up, though the reduction in dementia diagnoses alone did not reach statistical significance on its own.
Hearing loss is another. The ACHIEVE trial, a large randomized trial published in The Lancet in 2023, found that fitting hearing aids didn't measurably slow cognitive decline across its full study population, but it did slow decline by 48% over three years in a pre-specified subgroup of participants who were already at higher cardiovascular and cognitive risk — the group researchers think stands to benefit the most from correcting hearing loss.
Physical activity has some of the more visually concrete data. In a year-long randomized trial published in PNAS, previously sedentary older adults assigned to a 40-minute, three-times-a-week walking program saw their hippocampus — the brain region most tied to memory formation — grow by roughly 2% in volume, compared with shrinkage in a stretching-only comparison group. Two percent sounds modest, but the researchers noted it effectively reversed one to two years' worth of typical age-related volume loss in that region.
Social connection matters too, though two related ideas aren't identical. A UK Biobank cohort study following more than 155,000 adults for close to nine years found that social isolation — spending very little time with other people — was linked to a 62% higher rate of incident dementia, while loneliness, the subjective feeling of being alone, was not independently linked once other factors were accounted for. That's worth knowing before assuming that feeling lonely carries the same measured risk as consistently going without company.
Sleep has the clearest mechanistic story, even though it isn't formally one of the Lancet Commission's 14 named factors. Deep sleep drives the glymphatic system, a clearance network that flushes metabolic waste — including amyloid-beta and tau, the two proteins most associated with Alzheimer's pathology — out of brain tissue and into the bloodstream. Human sleep-deprivation studies have found measurably higher morning levels of these proteins after a night of disrupted sleep compared with normal sleep, which is a large part of why sleep quality keeps showing up in dementia-prevention research.
Training your brain like a muscle: what actually held up in a real trial
"Brain training" is heavily marketed, but the actual trial evidence is far more specific than the industry lets on. The best long-term data comes from the ACTIVE study, a randomized trial that assigned more than 2,800 healthy older adults to one of three structured cognitive-training programs — memory training, reasoning training, or speed-of-processing training — or to a no-contact control group. At 10-year follow-up, participants who received speed-of-processing training had a 29% lower rate of dementia diagnosis compared with the control group, and each additional completed training session was associated with roughly a further 10% reduction in risk — a genuine dose-response relationship, the kind of pattern researchers weight heavily. Extended 20-year follow-up data found that participants who also received periodic booster sessions were roughly 25% less likely to be diagnosed with dementia. The important, honest caveat: the memory-training and reasoning-training arms of that same trial did not show the same reduction. Not every style of "brain game" produced the same effect in the same study — a real problem for apps that market generic puzzle games as broadly protective against dementia.
Separately, one of the best-replicated findings in learning science is the testing effect, also called retrieval practice: actively trying to recall information from memory produces stronger, longer-lasting retention than re-reading or passively reviewing the same material for the same amount of time. Decades of controlled studies across psychology and education research show this effect holding up consistently across age groups and types of material, and it tends to outperform more familiar study strategies like highlighting or re-reading. In practice, that means quizzing yourself on a name, a shopping list, or a new skill — rather than just looking it up again — builds stronger retention, and spacing that practice out over several days works better than cramming it into one sitting.
Supplements: an honest look at what has real evidence — and what's oversold
Memory supplements are one of the most heavily marketed categories in wellness, and the research behind the most popular ingredients is narrower — and far more population-specific — than the marketing implies.
B vitamins have the most interesting evidence, within real limits. In the VITACOG trial, 271 adults over 70 with mild cognitive impairment took high-dose folic acid, B6, and B12 for two years. Among the subset who started with elevated homocysteine — a blood marker checked with a simple test, defined in the trial as above roughly 13 µmol/L — the treatment group showed up to 53% less brain shrinkage per year than the placebo group, concentrated in regions tied to Alzheimer's pathology. That's a genuine, published finding, but it's specific to people already diagnosed with MCI who also confirm elevated homocysteine on a blood test. It isn't evidence that B vitamins sharpen memory in someone with normal B12 and homocysteine levels.
Omega-3 fatty acids have solid evidence for heart health, but the evidence specifically for memory and cognitive decline is much weaker. A Cochrane systematic review pooling three randomized trials and more than 3,500 participants found no benefit of omega-3 supplementation on standard cognitive test scores compared with placebo, and none of the trials it reviewed found a reduced rate of new dementia diagnoses. More recent large trials have reached similarly negative conclusions, including in people carrying a genetic risk variant for Alzheimer's disease. Fish oil isn't risky for most people, but "good for your heart" hasn't translated into "proven to protect memory" in the way marketing often implies.
Ginkgo biloba is the one we'd push back on hardest. The NIH-funded Ginkgo Evaluation of Memory (GEM) study — a randomized, placebo-controlled trial of more than 3,000 older adults followed for a median of about six years — found that 120 mg of ginkgo twice daily did not reduce the overall rate of dementia or Alzheimer's disease compared with placebo, in people with normal cognition or mild impairment alike. It remains one of the more rigorously disproven memory-supplement ingredients on the market, despite continuing to be sold under memory-focused branding.
Apoaequorin-based supplements are a useful cautionary example of how far marketing can outrun evidence. Following FTC and New York Attorney General action, a federal court ordered the maker of the best-known apoaequorin supplement to stop advertising specific memory-improvement claims, after regulators found the company lacked reliable evidence that the ingredient — a protein originally isolated from jellyfish — reaches the brain when taken orally; the company's own submitted safety data showed it is largely broken down in the stomach. A jury later found many of the marketed claims lacked reliable scientific support. It's a reminder to look for independent, peer-reviewed evidence — not just a company's own funded studies — before trusting a specific memory-supplement brand's claims.
When memory changes are more than normal aging
Occasionally misplacing an item, blanking on a name that comes back to you later, or losing your train of thought are typical and, on their own, not cause for alarm. It's a different picture when someone repeatedly asks the same question, gets lost in a familiar neighborhood, struggles with a task they've always handled easily, or shows a noticeable change in personality or judgment — these are reasons to get a real medical evaluation rather than manage things with a routine or a supplement. Sudden confusion that comes on within hours needs emergency care rather than a wait-and-see approach, since it can signal a stroke, a severe infection, or another acute medical event rather than gradual age-related change.
Our take
Of everything we reviewed, the interventions with the strongest and most consistent trial evidence work on the body first and the brain second: managing blood pressure, treating hearing loss (particularly for people already at elevated cardiovascular or cognitive risk), staying physically active, protecting sleep, and maintaining real social contact. Speed-of-processing cognitive training has genuine randomized-trial evidence behind it specifically — not "brain games" as a broad category — and retrieval practice, testing yourself instead of re-reading, is one of the best-replicated findings in all of learning science. Supplements are the area most out of step with their own marketing: B vitamins show a real but narrow benefit tied to a specific, testable blood marker in people already diagnosed with MCI, while omega-3 and ginkgo have not shown a cognition-specific benefit in the largest trials designed to find one. None of this reverses memory loss that has already set in — it's risk-reduction and support for the brain you have going forward, and any real, persistent change in memory or thinking is worth bringing to a doctor rather than addressing with a routine alone.
If a doctor confirms elevated homocysteine is worth addressing
The VITACOG evidence for B vitamins applies to a specific, testable situation — mild cognitive impairment plus a blood homocysteine level above roughly 13 µmol/L — not general memory support for everyone. If a doctor has run that test and thinks a B-complex supplement is worth trying, look for a third-party-tested product that lists specific doses of folic acid, B6, and B12 rather than a vague proprietary blend.
See B-complex supplement options on AmazonAs an Amazon Associate, we earn from qualifying purchases.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results from any supplement, exercise habit, or routine change vary from person to person. Talk to a healthcare provider before starting any new supplement or exercise program, before interpreting a homocysteine or B12 test, and about any real or persistent changes in memory or thinking.